Status:
COMPLETED
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Renal Transplant
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Aim of study is to provide safety and tolerability data on enteric-coated mycophenolate sodium in regard to adverse events, serious adverse events and patient and graft survival. After successful comp...
Eligibility Criteria
Inclusion
- Cadaveric or living donor kidney transplant recipients who completed the study CERL080A0107
Exclusion
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
April 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00149916
Start Date
April 1 2000
Last Update
November 2 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.